nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—Ponatinib—KDR—age related macular degeneration	0.0336	1	CrCbGaD
Imatinib—ABCA3—eye—age related macular degeneration	0.00907	0.138	CbGeAlD
Imatinib—PIP4K2C—retina—age related macular degeneration	0.00512	0.0779	CbGeAlD
Imatinib—CA3—connective tissue—age related macular degeneration	0.00475	0.0723	CbGeAlD
Imatinib—PDGFRA—connective tissue—age related macular degeneration	0.00365	0.0555	CbGeAlD
Imatinib—CA12—eye—age related macular degeneration	0.00349	0.0531	CbGeAlD
Imatinib—CA12—connective tissue—age related macular degeneration	0.00337	0.0512	CbGeAlD
Imatinib—CSF1R—eye—age related macular degeneration	0.00333	0.0507	CbGeAlD
Imatinib—CSF1R—connective tissue—age related macular degeneration	0.00321	0.0488	CbGeAlD
Imatinib—SLC47A1—eye—age related macular degeneration	0.00304	0.0463	CbGeAlD
Imatinib—PDGFRB—eye—age related macular degeneration	0.00296	0.045	CbGeAlD
Imatinib—KIT—connective tissue—age related macular degeneration	0.00292	0.0443	CbGeAlD
Imatinib—PDGFRB—connective tissue—age related macular degeneration	0.00285	0.0433	CbGeAlD
Imatinib—CA1—eye—age related macular degeneration	0.00277	0.0421	CbGeAlD
Imatinib—ABL1—eye—age related macular degeneration	0.00263	0.0401	CbGeAlD
Imatinib—ABL1—retina—age related macular degeneration	0.00261	0.0397	CbGeAlD
Imatinib—ABL1—connective tissue—age related macular degeneration	0.00254	0.0386	CbGeAlD
Imatinib—CA2—eye—age related macular degeneration	0.00179	0.0273	CbGeAlD
Imatinib—CA2—retina—age related macular degeneration	0.00178	0.027	CbGeAlD
Imatinib—CA2—connective tissue—age related macular degeneration	0.00173	0.0263	CbGeAlD
Imatinib—PTGS1—connective tissue—age related macular degeneration	0.00134	0.0203	CbGeAlD
Imatinib—ABCB1—retina—age related macular degeneration	0.000812	0.0123	CbGeAlD
Imatinib—PDGFRB—Signaling Pathways—ABCA4—age related macular degeneration	0.000394	0.000437	CbGpPWpGaD
Imatinib—LCK—Disease—RHO—age related macular degeneration	0.000393	0.000436	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—RPE65—age related macular degeneration	0.000392	0.000435	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00039	0.000433	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000386	0.000429	CbGpPWpGaD
Imatinib—CA6—Metabolism—CD36—age related macular degeneration	0.000386	0.000428	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000382	0.000424	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—RHO—age related macular degeneration	0.00038	0.000422	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.000375	0.000416	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—NMNAT1—age related macular degeneration	0.000372	0.000413	CbGpPWpGaD
Imatinib—CA9—Metabolism—LIPC—age related macular degeneration	0.000371	0.000412	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—SLC16A8—age related macular degeneration	0.000366	0.000407	CbGpPWpGaD
Imatinib—LCK—Immune System—CFH—age related macular degeneration	0.000364	0.000405	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—CD36—age related macular degeneration	0.000364	0.000404	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—SLC16A8—age related macular degeneration	0.000363	0.000403	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—SLC16A8—age related macular degeneration	0.000362	0.000402	CbGpPWpGaD
Imatinib—CA7—Metabolism—CD36—age related macular degeneration	0.00036	0.0004	CbGpPWpGaD
Imatinib—PDGFRB—Focal Adhesion—VEGFA—age related macular degeneration	0.000359	0.000399	CbGpPWpGaD
Imatinib—KIT—Disease—CST3—age related macular degeneration	0.000359	0.000398	CbGpPWpGaD
Imatinib—CA9—Metabolism—CETP—age related macular degeneration	0.000358	0.000397	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000356	0.000395	CbGpPWpGaD
Imatinib—LCK—Immune System—CFB—age related macular degeneration	0.000353	0.000392	CbGpPWpGaD
Imatinib—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.000352	0.000391	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—SLC16A8—age related macular degeneration	0.000352	0.000391	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—CD36—age related macular degeneration	0.00035	0.000388	CbGpPWpGaD
Imatinib—CA14—Metabolism—APOE—age related macular degeneration	0.000349	0.000388	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000349	0.000387	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—C3—age related macular degeneration	0.000345	0.000383	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—CD36—age related macular degeneration	0.000345	0.000383	CbGpPWpGaD
Imatinib—ALB—Platelet degranulation—VEGFA—age related macular degeneration	0.000344	0.000382	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—RHO—age related macular degeneration	0.000343	0.00038	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—CD36—age related macular degeneration	0.000343	0.00038	CbGpPWpGaD
Imatinib—CA6—Metabolism—APOE—age related macular degeneration	0.00034	0.000378	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CST3—age related macular degeneration	0.00034	0.000377	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—SLC16A8—age related macular degeneration	0.000338	0.000375	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—CD36—age related macular degeneration	0.000336	0.000373	CbGpPWpGaD
Imatinib—CA12—Metabolism—CD36—age related macular degeneration	0.000334	0.000371	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—C3—age related macular degeneration	0.000331	0.000368	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—CD36—age related macular degeneration	0.000331	0.000367	CbGpPWpGaD
Imatinib—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.000328	0.000364	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—CRP—age related macular degeneration	0.000328	0.000364	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—C3—age related macular degeneration	0.000327	0.000363	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ELOVL4—age related macular degeneration	0.000325	0.000361	CbGpPWpGaD
Imatinib—KIT—Disease—TGFBR1—age related macular degeneration	0.000322	0.000358	CbGpPWpGaD
Imatinib—ALB—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.000321	0.000356	CbGpPWpGaD
Imatinib—ALB—Metabolism—NMNAT1—age related macular degeneration	0.000321	0.000356	CbGpPWpGaD
Imatinib—CA7—Metabolism—APOE—age related macular degeneration	0.000318	0.000353	CbGpPWpGaD
Imatinib—KIT—Immune System—SQSTM1—age related macular degeneration	0.000316	0.000351	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—ABCA4—age related macular degeneration	0.000316	0.000351	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—TLR4—age related macular degeneration	0.000315	0.000349	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—C3—age related macular degeneration	0.000314	0.000348	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—CRP—age related macular degeneration	0.000311	0.000345	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—CD36—age related macular degeneration	0.00031	0.000345	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000308	0.000342	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CST3—age related macular degeneration	0.000306	0.00034	CbGpPWpGaD
Imatinib—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.000305	0.000338	CbGpPWpGaD
Imatinib—PDGFRA—Disease—TGFBR1—age related macular degeneration	0.000305	0.000338	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—CD36—age related macular degeneration	0.000303	0.000336	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—SQSTM1—age related macular degeneration	0.000299	0.000332	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—CD36—age related macular degeneration	0.000298	0.000331	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—TLR4—age related macular degeneration	0.000298	0.000331	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—KDR—age related macular degeneration	0.000296	0.000329	CbGpPWpGaD
Imatinib—CA12—Metabolism—APOE—age related macular degeneration	0.000294	0.000327	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—C3—age related macular degeneration	0.000294	0.000327	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—NMNAT1—age related macular degeneration	0.000288	0.00032	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—C3—age related macular degeneration	0.000287	0.000318	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—C3—age related macular degeneration	0.000282	0.000314	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.000281	0.000312	CbGpPWpGaD
Imatinib—ALB—Metabolism—ELOVL4—age related macular degeneration	0.00028	0.000311	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—CRP—age related macular degeneration	0.00028	0.000311	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000279	0.00031	CbGpPWpGaD
Imatinib—LCK—Hemostasis—CD36—age related macular degeneration	0.000277	0.000307	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—RHO—age related macular degeneration	0.000275	0.000305	CbGpPWpGaD
Imatinib—PDGFRB—Disease—TGFBR1—age related macular degeneration	0.000275	0.000305	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—CRP—age related macular degeneration	0.000273	0.000303	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—SQSTM1—age related macular degeneration	0.00027	0.000299	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—TLR4—age related macular degeneration	0.000268	0.000298	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.000265	0.000294	CbGpPWpGaD
Imatinib—ABL1—Immune System—SQSTM1—age related macular degeneration	0.000263	0.000292	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.000262	0.000291	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—SLC16A8—age related macular degeneration	0.000262	0.000291	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—TLR4—age related macular degeneration	0.000261	0.00029	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00026	0.000288	CbGpPWpGaD
Imatinib—LCK—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000256	0.000284	CbGpPWpGaD
Imatinib—CA2—Metabolism—CD36—age related macular degeneration	0.000255	0.000283	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ELOVL4—age related macular degeneration	0.000252	0.000279	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000251	0.000278	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—CD36—age related macular degeneration	0.000249	0.000277	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.000246	0.000273	CbGpPWpGaD
Imatinib—LCK—Disease—CST3—age related macular degeneration	0.000245	0.000273	CbGpPWpGaD
Imatinib—CA1—Metabolism—CD36—age related macular degeneration	0.000245	0.000272	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—CD36—age related macular degeneration	0.000239	0.000266	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000238	0.000265	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—C3—age related macular degeneration	0.000236	0.000262	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000234	0.00026	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000233	0.000259	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.000231	0.000257	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.000229	0.000255	CbGpPWpGaD
Imatinib—ABL1—Axon guidance—VEGFA—age related macular degeneration	0.000229	0.000254	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—C3—age related macular degeneration	0.000227	0.000252	CbGpPWpGaD
Imatinib—ALB—Metabolism—SLC16A8—age related macular degeneration	0.000226	0.000251	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TGFBR1—age related macular degeneration	0.000226	0.00025	CbGpPWpGaD
Imatinib—CA2—Metabolism—APOE—age related macular degeneration	0.000225	0.00025	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000225	0.00025	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—CRP—age related macular degeneration	0.000225	0.000249	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	0.000224	0.000249	CbGpPWpGaD
Imatinib—LCK—Disease—TGFBR1—age related macular degeneration	0.00022	0.000245	CbGpPWpGaD
Imatinib—LCK—Immune System—SQSTM1—age related macular degeneration	0.000216	0.00024	CbGpPWpGaD
Imatinib—CA1—Metabolism—APOE—age related macular degeneration	0.000216	0.00024	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—TLR4—age related macular degeneration	0.000215	0.000239	CbGpPWpGaD
Imatinib—CA9—Metabolism—CD36—age related macular degeneration	0.000215	0.000239	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TGFBR1—age related macular degeneration	0.000213	0.000237	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000213	0.000236	CbGpPWpGaD
Imatinib—KIT—Immune System—CD36—age related macular degeneration	0.000212	0.000235	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000209	0.000232	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000207	0.00023	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000205	0.000228	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—SQSTM1—age related macular degeneration	0.000204	0.000227	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—SLC16A8—age related macular degeneration	0.000203	0.000225	CbGpPWpGaD
Imatinib—KIT—Immune System—C3—age related macular degeneration	0.000201	0.000223	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CD36—age related macular degeneration	0.000201	0.000223	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.000198	0.00022	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.000196	0.000218	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—SQSTM1—age related macular degeneration	0.000194	0.000215	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TGFBR1—age related macular degeneration	0.000192	0.000214	CbGpPWpGaD
Imatinib—KIT—Immune System—CRP—age related macular degeneration	0.000191	0.000212	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—C3—age related macular degeneration	0.00019	0.000211	CbGpPWpGaD
Imatinib—CA9—Metabolism—APOE—age related macular degeneration	0.00019	0.000211	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—LIPC—age related macular degeneration	0.000187	0.000208	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.000187	0.000207	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—LIPC—age related macular degeneration	0.000186	0.000206	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—LIPC—age related macular degeneration	0.000185	0.000206	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.000185	0.000205	CbGpPWpGaD
Imatinib—KIT—Immune System—TLR4—age related macular degeneration	0.000183	0.000203	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000182	0.000202	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CRP—age related macular degeneration	0.000181	0.000201	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CETP—age related macular degeneration	0.000181	0.000201	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD36—age related macular degeneration	0.000181	0.000201	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—LIPC—age related macular degeneration	0.00018	0.0002	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CETP—age related macular degeneration	0.000179	0.000199	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CETP—age related macular degeneration	0.000179	0.000199	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—C3—age related macular degeneration	0.000177	0.000197	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD36—age related macular degeneration	0.000176	0.000196	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000175	0.000195	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—SQSTM1—age related macular degeneration	0.000174	0.000194	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CETP—age related macular degeneration	0.000174	0.000193	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—TLR4—age related macular degeneration	0.000173	0.000193	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000173	0.000192	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—LIPC—age related macular degeneration	0.000173	0.000192	CbGpPWpGaD
Imatinib—KIT—Disease—APOE—age related macular degeneration	0.000173	0.000192	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—C3—age related macular degeneration	0.000171	0.00019	CbGpPWpGaD
Imatinib—ABL1—Immune System—C3—age related macular degeneration	0.000167	0.000185	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CETP—age related macular degeneration	0.000167	0.000185	CbGpPWpGaD
Imatinib—ALB—Hemostasis—CD36—age related macular degeneration	0.000165	0.000184	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—APOE—age related macular degeneration	0.000165	0.000183	CbGpPWpGaD
Imatinib—PDGFRA—Disease—APOE—age related macular degeneration	0.000163	0.000181	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—VEGFA—age related macular degeneration	0.000163	0.000181	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CRP—age related macular degeneration	0.000163	0.000181	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—KDR—age related macular degeneration	0.000162	0.00018	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—VEGFA—age related macular degeneration	0.00016	0.000178	CbGpPWpGaD
Imatinib—ABL1—Immune System—CRP—age related macular degeneration	0.000159	0.000176	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.000158	0.000175	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—TLR4—age related macular degeneration	0.000156	0.000173	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TGFBR1—age related macular degeneration	0.000154	0.000171	CbGpPWpGaD
Imatinib—ALB—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000153	0.00017	CbGpPWpGaD
Imatinib—ABL1—Immune System—TLR4—age related macular degeneration	0.000152	0.000169	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000151	0.000168	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000151	0.000167	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00015	0.000167	CbGpPWpGaD
Imatinib—PDGFRB—Disease—APOE—age related macular degeneration	0.000147	0.000164	CbGpPWpGaD
Imatinib—LCK—Immune System—CD36—age related macular degeneration	0.000145	0.000161	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—SQSTM1—age related macular degeneration	0.00014	0.000155	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CCL2—age related macular degeneration	0.000139	0.000154	CbGpPWpGaD
Imatinib—LCK—Immune System—C3—age related macular degeneration	0.000137	0.000153	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000135	0.00015	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—LIPC—age related macular degeneration	0.000134	0.000149	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000133	0.000147	CbGpPWpGaD
Imatinib—LCK—Hemostasis—VEGFA—age related macular degeneration	0.000132	0.000146	CbGpPWpGaD
Imatinib—LCK—Immune System—CRP—age related macular degeneration	0.000131	0.000145	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—C3—age related macular degeneration	0.00013	0.000144	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CETP—age related macular degeneration	0.00013	0.000144	CbGpPWpGaD
Imatinib—LCK—Immune System—TLR4—age related macular degeneration	0.000125	0.000139	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000123	0.000137	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—C3—age related macular degeneration	0.000123	0.000137	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000122	0.000135	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—APOE—age related macular degeneration	0.000121	0.000134	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000119	0.000132	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—KDR—age related macular degeneration	0.000118	0.000132	CbGpPWpGaD
Imatinib—LCK—Disease—APOE—age related macular degeneration	0.000118	0.000131	CbGpPWpGaD
Imatinib—ALB—Metabolism—LIPC—age related macular degeneration	0.000116	0.000128	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—APOE—age related macular degeneration	0.000114	0.000127	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—KDR—age related macular degeneration	0.000112	0.000125	CbGpPWpGaD
Imatinib—ALB—Metabolism—CETP—age related macular degeneration	0.000112	0.000124	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—C3—age related macular degeneration	0.000111	0.000123	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000109	0.000121	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CD36—age related macular degeneration	0.000109	0.000121	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CD36—age related macular degeneration	0.000108	0.00012	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CD36—age related macular degeneration	0.000108	0.000119	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000105	0.000117	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CD36—age related macular degeneration	0.000104	0.000116	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—LIPC—age related macular degeneration	0.000104	0.000115	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—APOE—age related macular degeneration	0.000103	0.000114	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CCL2—age related macular degeneration	0.000102	0.000113	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000101	0.000113	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—KDR—age related macular degeneration	0.000101	0.000112	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CD36—age related macular degeneration	0.0001	0.000111	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CETP—age related macular degeneration	0.0001	0.000111	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CETP—age related macular degeneration	9.78e-05	0.000109	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CCL2—age related macular degeneration	9.62e-05	0.000107	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—APOE—age related macular degeneration	9.59e-05	0.000106	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—LIPC—age related macular degeneration	9.55e-05	0.000106	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—APOE—age related macular degeneration	9.5e-05	0.000106	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—APOE—age related macular degeneration	9.49e-05	0.000105	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—LIPC—age related macular degeneration	9.47e-05	0.000105	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	9.29e-05	0.000103	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CETP—age related macular degeneration	9.21e-05	0.000102	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—APOE—age related macular degeneration	9.21e-05	0.000102	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CETP—age related macular degeneration	9.13e-05	0.000101	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—VEGFA—age related macular degeneration	8.91e-05	9.89e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—C3—age related macular degeneration	8.89e-05	9.87e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—APOE—age related macular degeneration	8.84e-05	9.82e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CCL2—age related macular degeneration	8.67e-05	9.62e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—APOE—age related macular degeneration	8.28e-05	9.19e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—KDR—age related macular degeneration	8.11e-05	9e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—LIPC—age related macular degeneration	8.09e-05	8.98e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—VEGFA—age related macular degeneration	7.88e-05	8.74e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CETP—age related macular degeneration	7.81e-05	8.67e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CD36—age related macular degeneration	7.79e-05	8.65e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCL2—age related macular degeneration	6.96e-05	7.72e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—APOE—age related macular degeneration	6.87e-05	7.63e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—CD36—age related macular degeneration	6.71e-05	7.45e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—VEGFA—age related macular degeneration	6.53e-05	7.25e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—LIPC—age related macular degeneration	6.24e-05	6.93e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—VEGFA—age related macular degeneration	6.18e-05	6.86e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CETP—age related macular degeneration	6.02e-05	6.69e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CD36—age related macular degeneration	6.02e-05	6.68e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—APOE—age related macular degeneration	5.92e-05	6.57e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CD36—age related macular degeneration	5.88e-05	6.52e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—VEGFA—age related macular degeneration	5.57e-05	6.18e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CD36—age related macular degeneration	5.54e-05	6.15e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CD36—age related macular degeneration	5.49e-05	6.09e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—APOE—age related macular degeneration	5.31e-05	5.9e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—APOE—age related macular degeneration	5.18e-05	5.76e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—APOE—age related macular degeneration	4.88e-05	5.42e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—APOE—age related macular degeneration	4.84e-05	5.38e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CD36—age related macular degeneration	4.69e-05	5.21e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—VEGFA—age related macular degeneration	4.47e-05	4.96e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—APOE—age related macular degeneration	4.14e-05	4.59e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CD36—age related macular degeneration	3.62e-05	4.02e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOE—age related macular degeneration	3.19e-05	3.55e-05	CbGpPWpGaD
